Kozicz-Stankiewicz Anna Ewa 4
4 · Cibus, Inc. · Filed Jun 1, 2023
Insider Transaction Report
Form 4
Cibus, Inc.CLXT
Kozicz-Stankiewicz Anna Ewa
Director
Transactions
- Disposition to Issuer
Stock Option (Right-to-Buy)
2023-03-01−5,000→ 0 totalExercise: $4.55Exp: 2030-08-04→ Common Stock (5,000 underlying) - Disposition to Issuer
Stock Option (Right-to-Buy)
2023-03-01−34,900→ 0 totalExercise: $0.30Exp: 2032-06-13→ Common Stock (34,900 underlying) - Award
Stock Option (Right-to-Buy)
2023-03-01+34,900→ 34,900 totalExercise: $0.30Exp: 2032-06-13→ Common Stock (34,900 underlying) - Award
Stock Option (Right-to-Buy)
2023-03-01+5,000→ 5,000 totalExercise: $4.55Exp: 2030-08-04→ Common Stock (5,000 underlying) - Award
Stock Option (Right-to-Buy)
2023-03-01+12,761→ 12,761 totalExercise: $4.22Exp: 2031-05-27→ Common Stock (12,761 underlying) - Disposition to Issuer
Stock Option (Right-to-Buy)
2023-03-01−12,761→ 0 totalExercise: $4.22Exp: 2031-05-27→ Common Stock (12,761 underlying)
Footnotes (1)
- [F1]The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.